Immunology and Microbiology
Alemtuzumab
100%
Autoimmunity
30%
B Cell
55%
Brain Derived Neurotrophic Factor
8%
CCR4
10%
CCR5
10%
CD14
8%
CD25
8%
CD3 Antigen
10%
CD4
8%
CD52 Antigen
8%
CD8
10%
Cell Death
50%
Cell Function
58%
Chemoattractant
8%
Chemokine
8%
Chemokine Receptor
10%
Chemotaxis
50%
CXCR3
20%
Cytokine Release
18%
Cytotoxic T-Cell
20%
Drug Mechanism
8%
Effector Cell
10%
Expanded Disability Status Scale
10%
Functional Status
8%
Human Embryonic Stem Cell
8%
Immune System
8%
Immunocompetent Cell
10%
Immunopathogenesis
10%
Inflammatory Cell
10%
Lymphocyte
8%
Lymphocyte Subpopulation
18%
Lymphocytopenia
10%
Magnetic Resonance Imaging
10%
Monocyte
50%
Multiple Sclerosis
25%
Myelin
16%
Natural Killer Cell
50%
Neural Stem Cell
50%
Regulatory B Cells
25%
Regulatory Cell
70%
Regulatory T Cell
55%
Relapsing Remitting Multiple Sclerosis
100%
Stem Cell
8%
Surface Property
10%
T Cell
65%
T-Helper Cell
20%
Neuroscience
Antioxidant
5%
Axon
10%
Calcium Channel
5%
Cell Death
100%
Cell Function
50%
Central Nervous System
5%
Chemokine
8%
Chemotaxis
50%
Cytotoxicity
5%
Eicosanoid Receptor
5%
Embryonic Stem Cell
8%
Fodrin
5%
In Vitro
16%
Ionophore
5%
Multiple Sclerosis
25%
Myelin
26%
Neural Stem Cell
50%
Neuronal Death
5%
Nicardipine
10%
Oligodendrocyte
55%
Oligodendrocyte Progenitor
100%
Progenitor Cell
100%
Reactive Oxygen Species
5%
Schwann Cell
10%
Staurosporine
5%
Stem Cell
8%
Subventricular Zone
10%
Pharmacology, Toxicology and Pharmaceutical Science
Alemtuzumab
50%
Biological Marker
10%
CD8 Antigen
30%
Chemokine Receptor
10%
Cytokine
10%
Expanded Disability Status Scale
10%
Gadolinium
10%
Immunopathogenesis
10%
Lymphocytopenia
10%
Multiple Sclerosis
50%
Nicardipine
7%
Pyruvic Acid
50%
Zinc Ion
50%
